Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) has entered into separate settlement arrangements with Mylan Inc. (NYSE: MYL) and its subsidiary, Mylan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE